ArticleJournal of cosmetic dermatology2025
A Deep Dive Into the Potential Antiaging Effects of Colla Corii Asini on the Skin: A Comparative Study.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Colla Corii Asini regulate collagen regeneration in UV exposure-induced skin photoaging in mice.Chinese medicine · 2025Article
- Valorization of aquaculture side streams from sea bream and sea bass by enzymatic hydrolysis and fractionation: chemical and biological insights.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSkin aging results in skin barrier damage and skin wrinkles. Oral Colla Corii Asini (CCA) can show significant antiaging effects. However, few studies have investigated the skin's antiaging effects of topical CCA. Here, we investigated and compared the effects of CCA crushed (CCAC) and its enzymatic digest, CCA oligopeptide (CCAO), on skin barrier function and wrinkle formation.
methodsCCAO and CCAC were prepared by enzymatic digestion and pulverization. HaCaT cells and HSF cells were selected as in vitro cell models. Cytotoxicity and cell proliferation were detected by MTT assay; scratch assay was used to evaluate the effect on cell migration; quantitative real-time PCR (qRT-PCR), immunofluorescence, and ELISA were used to determine the changes in expression of the barrier-related molecules (AQP3, FLG, and LOR) and antiwrinkle firming-related molecules (COL-1, COL-3, ELN, and MMP-1).
resultsMTT assay showed no significant cytotoxicity of CCAO and CCAC at < 2.5 mg/mL. After treating the cells with safe doses of CCAO and CCAC, HaCaT cell proliferation and migration were significantly enhanced, and there was no difference between the two effects. The expression levels of AQP3, FLG, and LOR were all significantly increased compared with the NC group, in which CCAO mainly promoted FLG and LOR expression, while CCAC mainly promoted the expression of AQP3. At the same time, CCAO and CCAC also significantly upregulated the expression levels of COL-1, COL-3 and ELN, and downregulated MMP-1 expression in HSF cells, and the effect of CCAO was more significant.
conclusionTopical application of CCA improves the skin barrier, increases collagen levels, and enhances skin elasticity, thus slowing down skin aging. CCAO is more easily absorbed and utilized by the skin due to its small molecular weight, which gives a better effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.